Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis

• An Exploratory Clinical Study of SCAR02 Targeting BCMA and CD19 for the Treatment of Refractory Autoimmune Diseases
  NCT06503224 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• CAR-T Cells Therapy for Patients With Autoimmune Diseases
  NCT07052565 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

How many recruiting trials involve Anti-BCMA and CD19 CART cells will be injected intravenously on a one-time basis?

2 recruiting trials across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.